Shukra Pharmaceuticals Ltd vs Zim Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 29.97 as of 12 Jun 15:30 . The P/E Ratio of Shukra Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Zim Laboratories Ltd changed from 16.1 on March 2021 to 54.9 on March 2026 . This represents a CAGR of 22.68% over 6 years The Market Cap of Shukra Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Zim Laboratories Ltd changed from ₹ 117.75 crore on March 2021 to ₹ 320.31 crore on March 2026 . This represents a CAGR of 18.15% over 6 years The revenue of Shukra Pharmaceuticals Ltd for the Mar '26 is ₹ 7.27 crore as compare to the Dec '25 revenue of ₹ 39.95 crore. This represent the decline of -81.8% The revenue of Zim Laboratories Ltd for the Mar '26 is ₹ 111.44 crore as compare to the Dec '25 revenue of ₹ 110.36 crore. This represent the growth of 0.98% The ebitda of Shukra Pharmaceuticals Ltd for the Mar '26 is ₹ 1.65 crore as compare to the Dec '25 ebitda of ₹ 27.95 crore. This represent the decline of -94.1% The ebitda of Zim Laboratories Ltd for the Mar '26 is ₹ 13.35 crore as compare to the Dec '25 ebitda of ₹ 14.51 crore. This represent the decline of -7.99% The net profit of Shukra Pharmaceuticals Ltd changed from ₹ 3.16 crore to ₹ -1.72 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Zim Laboratories Ltd changed from ₹ 4 crore to ₹ 3.74 crore over 8 quarters. This represents a CAGR of -3.30% The Dividend Payout of Shukra Pharmaceuticals Ltd changed from 10.47 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Zim Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016.
The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

About Zim Laboratories Ltd

Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra.
The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai.
The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company.
SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

FAQs for the comparison of Shukra Pharmaceuticals Ltd and Zim Laboratories Ltd

Which company has a larger market capitalization, Shukra Pharmaceuticals Ltd or Zim Laboratories Ltd?

Market cap of Shukra Pharmaceuticals Ltd is 1,312 Cr while Market cap of Zim Laboratories Ltd is 604 Cr

What are the key factors driving the stock performance of Shukra Pharmaceuticals Ltd and Zim Laboratories Ltd?

The stock performance of Shukra Pharmaceuticals Ltd and Zim Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shukra Pharmaceuticals Ltd and Zim Laboratories Ltd?

As of June 15, 2026, the Shukra Pharmaceuticals Ltd stock price is INR ₹29.97. On the other hand, Zim Laboratories Ltd stock price is INR ₹112.95.

How do dividend payouts of Shukra Pharmaceuticals Ltd and Zim Laboratories Ltd compare?

To compare the dividend payouts of Shukra Pharmaceuticals Ltd and Zim Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.